(3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one

C124H217N21O10 — CID 160519635

IUPAC(3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one
SMILESCC(C)CC1CCN(C(=O)[C@H](CC2CC2)N2CCN[C@@H](CC(C)(C)C)C2=O)CC1.CC(C)C[C@@H]1NCCN([C@@H](CC(C)C)C(=O)N2CCC(Cc3nc4c(n3C)CCC4)CC2)C1=O.CC(C)C[C@@H]1NCCN([C@@H](CC(C)C)C(=O)N2CCC(Cc3nccn3C(C)C)CC2)C1=O.CCCC1CCN(C(=O)[C@H](CC(C)C)N2CCN[C@@H](CC(C)C)C2=O)CC1.CCn1ccnc1CC1CCN(C(=O)[C@H](CC(C)C)N2CCN[C@@H](CC(C)C)C2=O)CC1
InChIInChI=1S/C27H45N5O2.C26H45N5O2.C25H43N5O2.C24H43N3O2.C22H41N3O2/c1-18(2)15-22-26(33)32(14-11-28-22)24(16-19(3)4)27(34)31-12-9-20(10-13-31)17-25-29-21-7-6-8-23(21)30(25)5;1-18(2)15-22-25(32)31(14-9-27-22)23(16-19(3)4)26(33)29-11-7-21(8-12-29)17-24-28-10-13-30(24)20(5)6;1-6-28-13-9-27-23(28)17-20-7-11-29(12-8-20)25(32)22(16-19(4)5)30-14-10-26-21(24(30)31)15-18(2)3;1-17(2)14-19-8-11-26(12-9-19)23(29)21(15-18-6-7-18)27-13-10-25-20(22(27)28)16-24(3,4)5;1-6-7-18-8-11-24(12-9-18)22(27)20(15-17(4)5)25-13-10-23-19(21(25)26)14-16(2)3/h18-20,22,24,28H,6-17H2,1-5H3;10,13,18-23,27H,7-9,11-12,14-17H2,1-6H3;9,13,18-22,26H,6-8,10-12,14-17H2,1-5H3;17-21,25H,6-16H2,1-5H3;16-20,23H,6-15H2,1-5H3/t22-,24-;22-,23-;21-,22-;20-,21-;19-,20-/m00000/s1
InChIKeyQUCIYKYZKFOHIC-ITKBTVFDSA-N
MW2162.24 g/mol
LogP16.37
Rot. Bonds41

About (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one

(3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one (PubChem CID 160519635) has the molecular formula C124H217N21O10 and a molecular weight of 2162.24 g/mol. Its IUPAC name is (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one.

Molecular Properties

Compound Name(3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one
PubChem CID160519635
Molecular FormulaC124H217N21O10
Molecular Weight2162.24 g/mol
Exact Mass2160.71
IUPAC Name(3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one
SMILESCC(C)CC1CCN(C(=O)[C@H](CC2CC2)N2CCN[C@@H](CC(C)(C)C)C2=O)CC1.CC(C)C[C@@H]1NCCN([C@@H](CC(C)C)C(=O)N2CCC(Cc3nc4c(n3C)CCC4)CC2)C1=O.CC(C)C[C@@H]1NCCN([C@@H](CC(C)C)C(=O)N2CCC(Cc3nccn3C(C)C)CC2)C1=O.CCCC1CCN(C(=O)[C@H](CC(C)C)N2CCN[C@@H](CC(C)C)C2=O)CC1.CCn1ccnc1CC1CCN(C(=O)[C@H](CC(C)C)N2CCN[C@@H](CC(C)C)C2=O)CC1
InChIInChI=1S/C27H45N5O2.C26H45N5O2.C25H43N5O2.C24H43N3O2.C22H41N3O2/c1-18(2)15-22-26(33)32(14-11-28-22)24(16-19(3)4)27(34)31-12-9-20(10-13-31)17-25-29-21-7-6-8-23(21)30(25)5;1-18(2)15-22-25(32)31(14-9-27-22)23(16-19(3)4)26(33)29-11-7-21(8-12-29)17-24-28-10-13-30(24)20(5)6;1-6-28-13-9-27-23(28)17-20-7-11-29(12-8-20)25(32)22(16-19(4)5)30-14-10-26-21(24(30)31)15-18(2)3;1-17(2)14-19-8-11-26(12-9-19)23(29)21(15-18-6-7-18)27-13-10-25-20(22(27)28)16-24(3,4)5;1-6-7-18-8-11-24(12-9-18)22(27)20(15-17(4)5)25-13-10-23-19(21(25)26)14-16(2)3/h18-20,22,24,28H,6-17H2,1-5H3;10,13,18-23,27H,7-9,11-12,14-17H2,1-6H3;9,13,18-22,26H,6-8,10-12,14-17H2,1-5H3;17-21,25H,6-16H2,1-5H3;16-20,23H,6-15H2,1-5H3/t22-,24-;22-,23-;21-,22-;20-,21-;19-,20-/m00000/s1
InChIKeyQUCIYKYZKFOHIC-ITKBTVFDSA-N
XLogP16.37
TPSA316.71 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds41
Heavy Atoms155
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002162.24
LogP ≤ 516.37
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Analyze (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one?
The IUPAC name of (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one (CID 160519635) is (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one.
What is the SMILES notation for (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one?
The canonical SMILES for (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one is CC(C)CC1CCN(C(=O)[C@H](CC2CC2)N2CCN[C@@H](CC(C)(C)C)C2=O)CC1.CC(C)C[C@@H]1NCCN([C@@H](CC(C)C)C(=O)N2CCC(Cc3nc4c(n3C)CCC4)CC2)C1=O.CC(C)C[C@@H]1NCCN([C@@H](CC(C)C)C(=O)N2CCC(Cc3nccn3C(C)C)CC2)C1=O.CCCC1CCN(C(=O)[C@H](CC(C)C)N2CCN[C@@H](CC(C)C)C2=O)CC1.CCn1ccnc1CC1CCN(C(=O)[C@H](CC(C)C)N2CCN[C@@H](CC(C)C)C2=O)CC1.
What is the InChIKey of (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one?
The InChIKey is QUCIYKYZKFOHIC-ITKBTVFDSA-N. The full InChI is InChI=1S/C27H45N5O2.C26H45N5O2.C25H43N5O2.C24H43N3O2.C22H41N3O2/c1-18(2)15-22-26(33)32(14-11-28-22)24(16-19(3)4)27(34)31-12-9-20(10-13-31)17-25-29-21-7-6-8-23(21)30(25)5;1-18(2)15-22-25(32)31(14-9-27-22)23(16-19(3)4)26(33)29-11-7-21(8-12-29)17-24-28-10-13-30(24)20(5)6;1-6-28-13-9-27-23(28)17-20-7-11-29(12-8-20)25(32)22(16-19(4)5)30-14-10-26-21(24(30)31)15-18(2)3;1-17(2)14-19-8-11-26(12-9-19)23(29)21(15-18-6-7-18)27-13-10-25-20(22(27)28)16-24(3,4)5;1-6-7-18-8-11-24(12-9-18)22(27)20(15-17(4)5)25-13-10-23-19(21(25)26)14-16(2)3/h18-20,22,24,28H,6-17H2,1-5H3;10,13,18-23,27H,7-9,11-12,14-17H2,1-6H3;9,13,18-22,26H,6-8,10-12,14-17H2,1-5H3;17-21,25H,6-16H2,1-5H3;16-20,23H,6-15H2,1-5H3/t22-,24-;22-,23-;21-,22-;20-,21-;19-,20-/m00000/s1.
What are the key properties of (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one?
(3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one has a molecular weight of 2162.24 g/mol, XLogP of 16.37, 41 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-1-[(2S)-3-cyclopropyl-1-[4-(2-methylpropyl)piperidin-1-yl]-1-oxopropan-2-yl]-3-(2,2-dimethylpropyl)piperazin-2-one;(3S)-1-[(2S)-1-[4-[(1-ethylimidazol-2-yl)methyl]piperidin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-[4-[(3-methyl-5,6-dihydro-4H-cyclopenta[d]imidazol-2-yl)methyl]piperidin-1-yl]-1-oxopentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-[4-[(1-propan-2-ylimidazol-2-yl)methyl]piperidin-1-yl]pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one;(3S)-1-[(2S)-4-methyl-1-oxo-1-(4-propylpiperidin-1-yl)pentan-2-yl]-3-(2-methylpropyl)piperazin-2-one is sourced from PubChem (CID 160519635), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).